Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional
Official Title: A Phase I Trial Assessing the Feasibility of Romidepsin Combined With Brentuximab Vedotin for Patients With Requiring Systemic Therapy for Cutaneous T-cell Lymphoma
Brief Summary: This is a Phase I Trial to assess the feasibility of Romidepsin combined with Brentuximab Vedotin for patients requiring Systemic Therapy for Cutaneous T-cell Lymphoma.